Emergex Vaccines
We work on addressing some of the world’s most immediate health threats including viral diseases such as Dengue Fever, Zika, Ebola and pandemic Flu, as well as serious intra-cellular bacterial infections, and we have a growing pipeline of vaccine candidates.
Latest news
- Emergex Strengthens Senior Management Team 23 February 2021
- Emergex Notes U.S. Government Reports Highlighting the Importance of T-Cell Immunity in Controlling Viral Infections 28 January 2021
- Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine 5 January 2021